Skip to main content
Clinical Trials/NCT03380260
NCT03380260
Completed
Not Applicable

Investigating Neural Processing of Social Stimuli: Investigating a Neurobehavioral Mechanism of Paranoia

The University of Texas at Dallas1 site in 1 country70 target enrollmentJune 1, 2017
ConditionsHealthy Adults

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy Adults
Sponsor
The University of Texas at Dallas
Enrollment
70
Locations
1
Primary Endpoint
Resting cerebral blood flow (CBF)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The primary goal of the present study is to test whether neural activity in brain regions associated with processing threat and social stimuli may underlie paranoid thinking.

Detailed Description

Paranoia is a prominent symptom of psychosis that occurs in several other diagnoses, as well as the general population, and that is associated with significant distress and impairment. Previous research suggests that increased baseline activity of the amygdala and related neural circuits may serve as a mechanism for paranoid ideation. This exploratory study will use a paranoia induction procedure in healthy individuals who vary in pre-existing levels of paranoid ideation to test whether increases in self-reported paranoia are accompanied by increases in resting cerebral blood flow (CBF), decreased stimulus-driven neural activity in social processing networks, and increased behavioral perceptions of untrustworthiness. Participants will be randomly assigned to participate in a paranoia induction procedure or a control condition and will then complete neuroimaging and behavioral assessments.

Registry
clinicaltrials.gov
Start Date
June 1, 2017
End Date
April 1, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amy Pinkham

Associate Professor

The University of Texas at Dallas

Eligibility Criteria

Inclusion Criteria

  • between the ages of 18 and 55

Exclusion Criteria

  • current psychiatric diagnosis
  • current use of psychotropic medications
  • history of head trauma with loss of consciousness for more than 15 minutes
  • presence of neurological or neurodegenerative disorder
  • sensory impairments that preclude assessment
  • presence of intellectual disability
  • contraindications for MRI (e.g., metallic implants or pregnancy)

Outcomes

Primary Outcomes

Resting cerebral blood flow (CBF)

Time Frame: CBF measurements will be obtained during the study visit and will last approximately 9 minutes.

CBF in amygdala and related neural circuits

Secondary Outcomes

  • Self-reported paranoid ideation(Data will be obtained during the study visit and will last approximately 5 minutes.)
  • Amount of Neural Activity(Measurements will be obtained during the study visit and will last approximately 25 minutes.)
  • Ratings of Trustworthiness(Data will be obtained during the study visit and will last approximately 12 minutes.)

Study Sites (1)

Loading locations...

Similar Trials